Annalisa Santisi
Catania, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Janus kinase inhibitors after ruxolitinib failure in myelofibrosis: A systematic review and pooled analysis of phase 3 efficacy and integrated safety across clinical trials and real-world evidence.
Journal: British journal of haematology
Published: June 15, 2026
Hepcidin as a Molecular Hub of Iron Homeostasis: From BMP-SMAD Signaling to Therapeutic Modulation.
Journal: Biomolecules
Published: May 29, 2026
Pistachio Leaf Extract Modulates Redox-Dependent Mitochondrial and Metabolic Responses in Ethanol-Stressed HepG2 Cells.
Journal: International journal of molecular sciences
Published: April 27, 2026
A systematic review of 47 published cases of extramedullary hematopoiesis in myelofibrosis: clinical patterns, treatment responses, and prognostic implications.
Journal: Annals of hematology
Published: February 28, 2026
Real-world single-center experience with pixantrone in DLBCL prior to its withdrawal: clinical outcomes and exploratory immunologic observations.
Journal: Annals of hematology
Published: January 12, 2026
Old Therapy, New Questions: Rethinking Phlebotomy in a Pharmacologic Landscape.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 22, 2025
Fish Oil Containing Pro-Resolving Mediators Enhances the Antioxidant System and Ameliorates LPS-Induced Inflammation in Human Bronchial Epithelial Cells.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 08, 2024
Enhanced Antitumor Activity by the Combination of Dasatinib and Selinexor in Chronic Myeloid Leukemia.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 23, 2024
(+)Alpha-Lipoic Acid Regulates Lipid Metabolism Gene Expression and Lipidic Profile in a Cellular Model of Fatty Acid Overload.
Journal: Frontiers in bioscience (Landmark edition)
Published: November 22, 2023
Showing 1-10 of 10
Last Updated: 09/26/2026